Verity Pharmaceuticals Inc.
Quick facts
Phase 3 pipeline
- Bacillus Calmette-Guerin: Strain TICE · Oncology / Immunology
BCG TICE is a live attenuated mycobacterial vaccine that stimulates innate and adaptive immune responses to enhance anti-tumor immunity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: